Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;21(5):1336-1349.
doi: 10.1007/s10461-016-1565-9.

Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men

George J Greene  1   2 , Greg Swann  1   2 , Angela J Fought  3 , Alex Carballo-Diéguez  4 , Thomas J Hope  5 , Patrick F Kiser  6 , Brian Mustanski  1   2 , Richard T D'Aquila  7
Affiliations

Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men

George J Greene et al. AIDS Behav. 2017 May.

Abstract

HIV prevention method preferences were evaluated among 512 U.S. men who have sex with men (MSM; median age: 22 years). Approximately 90 % consistently preferred one option across pairwise comparisons of condoms, daily oral pre-exposure prophylaxis (PrEP), and long-acting PrEP delivered via either an injectable or one of two types of PrEP implants differing in visibility. Condoms were most frequently preferred (33.8 %), followed by non-visible implants (21.5 %), and oral PrEP (17.0 %); HIV risk was reported by more choosing implants. In a follow-up question comparing the four PrEP options only, daily oral pills and non-visible implants were most frequently preferred (35.5 and 34.3 %, respectively), followed by injections (25.2 %) and visible implants (4.3 %). An inductive, open-coding approach determined that convenience, duration of protection, and privacy were the most commonly cited reasons for a PrEP method choice, and associated with self-report of HIV risk. Tailoring PrEP product development to privacy and other concerns important to those at highest HIV risk may improve HIV prevention.

Keywords: HIV; Homosexuality; Male; Pre-exposure prophylaxis; Prevention; Sexual behavior.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Rates of condomless anal sex (CAS) by preferred HIV prevention method among the total sample, men reporting not being in a relationship (NREL, n = 311), and men reporting being in a relationship (REL, n = 199)a aTwo participants did not report relationship status.
See this image and copyright information in PMC

References

    1. CDC. Diagnoses of HIV Infection in the United States and Dependent Areas, 2014. HIV Surveillance Report. 2015;26:1–123.
    1. CDC. HIV Surveillance - Men who have sex with men (MSM) 2015 Dec 15; Available from: http://www.cdc.gov/hiv/library/slideSets/index.html.
    1. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410. - PMC - PubMed
    1. Smith DK, Van Handel M, Wolitski RJ, Stryker JE, Hall HI, Prejean J, et al. Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015. 2015;64(46):1291–5. - PubMed
    1. Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Science translational medicine. 2012;4(151):151ra25. - PMC - PubMed

MeSH terms